Marit Habicher
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Marit Habicher has a total of 58 co-authors. Here are the top co-authors by number of shared publications:
- Michael Sander
Department of Anaesthesiology, Intensive Care Medicine and Pain Medicine, University Hospital Giessen, Justus-Liebig University Giessen, Giessen, Germany
7 shared publications Michael Sander
Department of Anaesthesiology, Operative Intensive Care Medicine and Pain Therapy, Justus Liebig University of Giessen, Giessen, Germany
4 shared publicationsChristian Koch
Department of Anaesthesiology, Operative Intensive Care Medicine and Pain Therapy, Justus Liebig University of Giessen, Giessen, Germany
3 shared publicationsEmmanuel Schneck
Department of Anaesthesiology, Operative Intensive Care Medicine and Pain Therapy, Justus Liebig University of Giessen, Giessen, Germany
3 shared publications- Emmanuel Schneck
Klinik für Anästhesiologie, operative Intensivmedizin und Schmerztherapie, Universitätsklinikum Gießen und Marburg (UKGM), Justus-Liebig-Universität Gießen, Gießen, Deutschland
3 shared publications Melanie Markmann
Department of Anaesthesiology, Operative Intensive Care Medicine and Pain Therapy, Justus Liebig University of Giessen, Giessen, Germany
3 shared publications
Latest Publications
- 29 April 2026
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 137 (1) , 264-268
Association between preoperative hold time of SGLT2 inhibitors and postoperative blood ketone concentration: an interim analysis of a multicentre prospective cohort study
- 29 April 2026
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 137 (1) , 264-268
Association between preoperative hold time of SGLT2 inhibitors and postoperative blood ketone concentration: an interim analysis of a multicentre prospective cohort study
- Open Access
- 25 February 2026
- Published by Springer Nature in BMC Urology
- Vol. 26 (1)
Enhanced recovery after radical cystectomy for bladder cancer: a prospective observational case -control study
Introduction: The perioperative management of patients undergoing major surgical interventions is a dynamic field, continually striving for advancements in quality, reduction of complications, and cost-effectiveness. The implementation of Enhanced Recovery After Surgery (ERAS) pathways has demonstrated remarkable success in various surgical disciplines, particularly in colorectal procedures. This study investigates whether the implementation of an ERAS protocol for radical cystectomy for bladder cancer at our institution results in a reduced complication rate compared to traditional standards.DRKS00035673 (retrospective) on 13th December 2024. Methods: This prospective observational case-control pilot study was conducted at the University Hospital Giessen, Germany. Following ethics committee approval, 30 patients were enrolled: 15 patients received perioperative management based on prevailing standard operating procedures, and the subsequent 15 patients were managed according to the newly developed ERAS protocol. The multidisciplinary team included urologists, anaesthesiologists, nursing staff, ICU staff, pharmacists, physiotherapists, dietitians, and administrative staff. Key components of the ERAS protocol included optimized pain management, early nutrition, thrombosis prophylaxis, intraoperative goal directed therapy and early mobilization. The primary outcome was the complication rate until the 30th postoperative day, while secondary outcomes included ICU and hospital mortality, length of stay, and quality of life assessed by the EQ-5D-5L questionnaire. Results: Thirty patients were included in the final analysis. Patients in the control group underwent radical cystectomy between September 2018 and December 2019, and those in the ERAS group between July 2020 and March 2021. There were no significant differences in basic characteristics between the groups. The primary outcome showed numeric but no statistically significant difference in complication rates (86.7% in the control group vs. 60% in the ERAS group, p=0.21). However, the cumulative POMS score was significantly higher in the control group (7.87 vs. 2.87, p<0.01), and the Clavien-Dindo score was significantly lower in the ERAS group (p=0.02). Quality of life was significantly improved in the ERAS group on the 7th and 30th postoperative day. Conclusion: Our pilot study suggests feasibility of ERAS implementation in radical cystectomy. The primary endpoint (overall complication rate) did not differ significantly between groups; however, ERAS was associated with lower complication severity and improved early postoperative quality of life, which should be interpreted as exploratory given the small, non-randomised sequential design. Larger multicentre prospective implementation studies are warranted to confirm these findings and to evaluate the influence of protocol adherence and individual ERAS elements. Trial registration: DRKS00035673 (retrospective) on 13th December 2024
- 25 February 2026
- Published by Springer Nature in BMC Urology
- Vol. 26 (1)
Open AccessEnhanced recovery after radical cystectomy for bladder cancer: a prospective observational case -control study
Introduction: The perioperative management of patients undergoing major surgical interventions is a dynamic field, continually striving for advancements in quality, reduction of complications, and cost-effectiveness. The implementation of Enhanced Recovery After Surgery (ERAS) pathways has demonstrated remarkable success in various surgical disciplines, particularly in colorectal procedures. This study investigates whether the implementation of an ERAS protocol for radical cystectomy for bladder cancer at our institution results in a reduced complication rate compared to traditional standards.DRKS00035673 (retrospective) on 13th December 2024. Methods: This prospective observational case-control pilot study was conducted at the University Hospital Giessen, Germany. Following ethics committee approval, 30 patients were enrolled: 15 patients received perioperative management based on prevailing standard operating procedures, and the subsequent 15 patients were managed according to the newly developed ERAS protocol. The multidisciplinary team included urologists, anaesthesiologists, nursing staff, ICU staff, pharmacists, physiotherapists, dietitians, and administrative staff. Key components of the ERAS protocol included optimized pain management, early nutrition, thrombosis prophylaxis, intraoperative goal directed therapy and early mobilization. The primary outcome was the complication rate until the 30th postoperative day, while secondary outcomes included ICU and hospital mortality, length of stay, and quality of life assessed by the EQ-5D-5L questionnaire. Results: Thirty patients were included in the final analysis. Patients in the control group underwent radical cystectomy between September 2018 and December 2019, and those in the ERAS group between July 2020 and March 2021. There were no significant differences in basic characteristics between the groups. The primary outcome showed numeric but no statistically significant difference in complication rates (86.7% in the control group vs. 60% in the ERAS group, p=0.21). However, the cumulative POMS score was significantly higher in the control group (7.87 vs. 2.87, p<0.01), and the Clavien-Dindo score was significantly lower in the ERAS group (p=0.02). Quality of life was significantly improved in the ERAS group on the 7th and 30th postoperative day. Conclusion: Our pilot study suggests feasibility of ERAS implementation in radical cystectomy. The primary endpoint (overall complication rate) did not differ significantly between groups; however, ERAS was associated with lower complication severity and improved early postoperative quality of life, which should be interpreted as exploratory given the small, non-randomised sequential design. Larger multicentre prospective implementation studies are warranted to confirm these findings and to evaluate the influence of protocol adherence and individual ERAS elements. Trial registration: DRKS00035673 (retrospective) on 13th December 2024
- Open Access
- 22 December 2025
- Published by Springer Nature in Journal of Anesthesia, Analgesia and Critical Care
- Vol. 5 (1)
Artificial intelligence-based predictive hemodynamic monitoring in conjunction with goal-directed therapy reduces duration, frequency, and severity of intraoperative hypotension in major maxillofacial and otolaryngological surgery—a prospective randomized controlled pilot trial
Background: Intraoperative hypotension (IOH) during non-cardiac surgery is associated with increased risk of postoperative complications, including acute kidney injury, myocardial injury, stroke, and mortality. Artificial intelligence-based predictive hemodynamic monitoring using the Hypotension Prediction Index (HPI), combined with goal-directed therapy (GDT), has been proposed to reduce IOH. However, its effectiveness in major maxillofacial and otolaryngologic surgery remains unclear. The purpose of the study was to assess whether HPI-guided management or classical GDT reduces IOH compared to standard care in patients undergoing major maxillofacial and otolaryngologic surgery. Methods: In this randomized controlled pilot trial at a university hospital, 75 patients were allocated to one of three groups: control ( n = 25), HPI-guided GDT ( n = 25), or classical GDT without HPI ( n = 25). In the control group, the advanced hemodynamic monitoring was blinded to the anesthesiologist. IOH was defined as mean arterial pressure (MAP) < 65 mmHg for > 1 min. Primary endpoints were the number and total duration of IOH episodes. Secondary endpoints included the time-weighted average MAP < 65 mmHg (TWA65) and postoperative complications. Results: Seventy-four patients were analyzed. The HPI group showed significantly fewer IOH episodes (median 3.0 vs. 7.0; p = 0.02) and shorter IOH duration (7.0 min vs. 46.0 min; p < 0.01) compared to control. No significant difference was observed between the classical GDT and control groups. Secondary outcomes were comparable across all groups. Conclusions: HPI-guided hemodynamic management significantly reduces the frequency and duration of IOH in major head and neck surgery. Larger studies are needed to evaluate effects on clinical outcomes. Trial registration: The trial was registered on clinicaltrials.gov (NCT04151264) on 14th October 2019.
- 22 December 2025
- Published by Springer Nature in Journal of Anesthesia, Analgesia and Critical Care
- Vol. 5 (1)
Open AccessArtificial intelligence-based predictive hemodynamic monitoring in conjunction with goal-directed therapy reduces duration, frequency, and severity of intraoperative hypotension in major maxillofacial and otolaryngological surgery—a prospective randomized controlled pilot trial
Background: Intraoperative hypotension (IOH) during non-cardiac surgery is associated with increased risk of postoperative complications, including acute kidney injury, myocardial injury, stroke, and mortality. Artificial intelligence-based predictive hemodynamic monitoring using the Hypotension Prediction Index (HPI), combined with goal-directed therapy (GDT), has been proposed to reduce IOH. However, its effectiveness in major maxillofacial and otolaryngologic surgery remains unclear. The purpose of the study was to assess whether HPI-guided management or classical GDT reduces IOH compared to standard care in patients undergoing major maxillofacial and otolaryngologic surgery. Methods: In this randomized controlled pilot trial at a university hospital, 75 patients were allocated to one of three groups: control ( n = 25), HPI-guided GDT ( n = 25), or classical GDT without HPI ( n = 25). In the control group, the advanced hemodynamic monitoring was blinded to the anesthesiologist. IOH was defined as mean arterial pressure (MAP) < 65 mmHg for > 1 min. Primary endpoints were the number and total duration of IOH episodes. Secondary endpoints included the time-weighted average MAP < 65 mmHg (TWA65) and postoperative complications. Results: Seventy-four patients were analyzed. The HPI group showed significantly fewer IOH episodes (median 3.0 vs. 7.0; p = 0.02) and shorter IOH duration (7.0 min vs. 46.0 min; p < 0.01) compared to control. No significant difference was observed between the classical GDT and control groups. Secondary outcomes were comparable across all groups. Conclusions: HPI-guided hemodynamic management significantly reduces the frequency and duration of IOH in major head and neck surgery. Larger studies are needed to evaluate effects on clinical outcomes. Trial registration: The trial was registered on clinicaltrials.gov (NCT04151264) on 14th October 2019.
- Open Access
- 30 October 2025
- Published by Springer Nature in Trials
- Vol. 26 (1) , 1-10
AI-supported non-invasive measurement for intraoperative hypotension reduction in major Orthopedic and trauma surgery—study protocol for a randomized clinical trial
Background: Intraoperative hypotension (IOH) is a common complication in non-cardiac surgeries, with significant impacts on postoperative outcomes such as acute kidney injury (AKI), myocardial injury after non-cardiac surgery (MINS), and postoperative cognitive dysfunction (delirium). Traditional non-invasive blood pressure monitoring often results in blind gaps through the discontinuous measurement, potentially missing critical hypotensive events. This study investigates the efficacy of a non-invasive, continuous AI-supported technology using the Hypotension Prediction Index (HPI) system, designed to predict and mitigate IOH, in reducing the incidence and severity of IOH and related complications in major orthopedic and trauma surgeries. Methods/design: This monocentric, randomized, prospective interventional trial will be conducted at the University Hospital Giessen. The study will include patients aged 45 years and older undergoing major orthopedic or trauma surgeries. Participants will be randomized into two groups: an intervention group receiving hemodynamic management using the ClearSight system in combination with a HPI-based treatment algorithm and a control group receiving standard care. The patients from the standard group also receive continuous cardiac output monitoring; however, this will be blinded to the anesthesiologist, to ensure the comparability of the measured hemodynamic parameters. The primary endpoint is the incidence, duration and severity of IOH, which is defined as MAP < 65 mmHg for at least one minute and which is calculated as the area under MAP < 65 mmHg and the time-weighted average (TWA) of MAP < 65 mmHg. Secondary endpoints include the occurrence of postoperative AKI (measured by KDIGO criteria), MINS (measured by high-sensitivity troponin I assays), and postoperative delirium. The study aims to recruit 150 patients, accounting for potential dropouts, to provide sufficient power to detect differences in the primary and secondary endpoints. Conclusion: This study aims to demonstrate improved intraoperative hemodynamic stability, with a reduction of hypotension and a reduced incidence of postoperative complications, potentially setting a new standard for non-invasive continuous monitoring in orthopedic and trauma patients. Trial registration: ClinicalTrials.gov NCT06291714. Registered on 4 March 2024.
- 30 October 2025
- Published by Springer Nature in Trials
- Vol. 26 (1) , 1-10
Open AccessAI-supported non-invasive measurement for intraoperative hypotension reduction in major Orthopedic and trauma surgery—study protocol for a randomized clinical trial
Background: Intraoperative hypotension (IOH) is a common complication in non-cardiac surgeries, with significant impacts on postoperative outcomes such as acute kidney injury (AKI), myocardial injury after non-cardiac surgery (MINS), and postoperative cognitive dysfunction (delirium). Traditional non-invasive blood pressure monitoring often results in blind gaps through the discontinuous measurement, potentially missing critical hypotensive events. This study investigates the efficacy of a non-invasive, continuous AI-supported technology using the Hypotension Prediction Index (HPI) system, designed to predict and mitigate IOH, in reducing the incidence and severity of IOH and related complications in major orthopedic and trauma surgeries. Methods/design: This monocentric, randomized, prospective interventional trial will be conducted at the University Hospital Giessen. The study will include patients aged 45 years and older undergoing major orthopedic or trauma surgeries. Participants will be randomized into two groups: an intervention group receiving hemodynamic management using the ClearSight system in combination with a HPI-based treatment algorithm and a control group receiving standard care. The patients from the standard group also receive continuous cardiac output monitoring; however, this will be blinded to the anesthesiologist, to ensure the comparability of the measured hemodynamic parameters. The primary endpoint is the incidence, duration and severity of IOH, which is defined as MAP < 65 mmHg for at least one minute and which is calculated as the area under MAP < 65 mmHg and the time-weighted average (TWA) of MAP < 65 mmHg. Secondary endpoints include the occurrence of postoperative AKI (measured by KDIGO criteria), MINS (measured by high-sensitivity troponin I assays), and postoperative delirium. The study aims to recruit 150 patients, accounting for potential dropouts, to provide sufficient power to detect differences in the primary and secondary endpoints. Conclusion: This study aims to demonstrate improved intraoperative hemodynamic stability, with a reduction of hypotension and a reduced incidence of postoperative complications, potentially setting a new standard for non-invasive continuous monitoring in orthopedic and trauma patients. Trial registration: ClinicalTrials.gov NCT06291714. Registered on 4 March 2024.
- Open Access
- 14 February 2025
- Published by Elsevier in Journal of Clinical Anesthesia
- Vol. 102, 111777
Perioperative goal-directed therapy with artificial intelligence to reduce the incidence of intraoperative hypotension and renal failure in patients undergoing lung surgery: A pilot study
- 14 February 2025
- Published by Elsevier in Journal of Clinical Anesthesia
- Vol. 102, 111777
Open AccessPerioperative goal-directed therapy with artificial intelligence to reduce the incidence of intraoperative hypotension and renal failure in patients undergoing lung surgery: A pilot study
- Top Cited PapersOpen Access
- 12 December 2024
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 134 (1) , 54-62
Association of intraoperative hypotension and cumulative norepinephrine dose with postoperative acute kidney injury in patients having noncardiac surgery: a retrospective cohort analysis
- 12 December 2024
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 134 (1) , 54-62
Top Cited PapersOpen AccessAssociation of intraoperative hypotension and cumulative norepinephrine dose with postoperative acute kidney injury in patients having noncardiac surgery: a retrospective cohort analysis
- Open Access
- 6 April 2023
- Published by Springer Nature in Journal of Orthopaedic Surgery and Research
- Vol. 18 (1) , 1-11
Goal-directed fluid therapy using uncalibrated pulse contour analysis and balanced crystalloid solutions during hip revision arthroplasty: a quality implementation project
Background: To implement a goal-directed fluid therapy (GDFT) protocol using crystalloids in hip revision arthroplasty surgery within a quality management project at a tertiary hospital using a monocentric, prospective observational study. Methods: Adult patients scheduled for elective hip revision arthroplasty surgery were screened for inclusion in this prospective study. Intraoperatively stroke volume (SV) was optimized within a previously published protocol using uncalibrated pulse contour analysis and balanced crystalloids. Quality of perioperative GDFT was assessed by protocol adherence, SV increase as well as the rate of perioperative complications. Findings were then compared to two different historical groups of a former trial: one receiving GDFT with colloids (prospective colloid group) and one standard fluid therapy (retrospective control group) throughout surgery. Statistical analysis constitutes exploratory data analyses and results are expressed as median with 25th and 75th percentiles, absolute and relative frequencies, and complication rates are further given with 95% confidence intervals for proportions using the normal approximation without continuity correction. Results: Sixty-six patients underwent GDFT using balanced crystalloids and were compared to 130 patients with GDFT using balanced colloids and 130 controls without GDFT fluid resuscitation. There was a comparable increase in SV (crystalloids: 65 (54–74 ml; colloids: 67.5 (60–75.25 ml) and total volume infused (crystalloids: 2575 (2000–4210) ml; colloids: 2435 (1760–3480) ml; and controls: 2210 (1658–3000) ml). Overall perioperative complications rates were similar (42.4% (95%CI 30.3–55.2%) for crystalloids and 49.2% (95%CI 40.4–58.1%) for colloids and lower compared to controls: 66.9% (95%CI 58.1–74.9)). Interestingly, a reduced number of hemorrhagic complications was observed within crystalloids: 30% (95%CI 19.6–42.9); colloids: 43% (95%CI 34.4–52.0); and controls: 62% (95%CI 52.6–69.9). There were no differences in the rate of admission to the post-anesthesia care unit or intensive care unit as well as the length of stay. Conclusions: Perioperative fluid management using a GDFT protocol with crystalloids in hip revision arthroplasty surgery was successfully implemented in daily clinical routine. Perioperative complications rates were reduced compared to a previous management without GDFT and comparable when using colloids. Trial registration: ClinicalTrials.gov identifier: NCT01753050.
- 6 April 2023
- Published by Springer Nature in Journal of Orthopaedic Surgery and Research
- Vol. 18 (1) , 1-11
Open AccessGoal-directed fluid therapy using uncalibrated pulse contour analysis and balanced crystalloid solutions during hip revision arthroplasty: a quality implementation project
Background: To implement a goal-directed fluid therapy (GDFT) protocol using crystalloids in hip revision arthroplasty surgery within a quality management project at a tertiary hospital using a monocentric, prospective observational study. Methods: Adult patients scheduled for elective hip revision arthroplasty surgery were screened for inclusion in this prospective study. Intraoperatively stroke volume (SV) was optimized within a previously published protocol using uncalibrated pulse contour analysis and balanced crystalloids. Quality of perioperative GDFT was assessed by protocol adherence, SV increase as well as the rate of perioperative complications. Findings were then compared to two different historical groups of a former trial: one receiving GDFT with colloids (prospective colloid group) and one standard fluid therapy (retrospective control group) throughout surgery. Statistical analysis constitutes exploratory data analyses and results are expressed as median with 25th and 75th percentiles, absolute and relative frequencies, and complication rates are further given with 95% confidence intervals for proportions using the normal approximation without continuity correction. Results: Sixty-six patients underwent GDFT using balanced crystalloids and were compared to 130 patients with GDFT using balanced colloids and 130 controls without GDFT fluid resuscitation. There was a comparable increase in SV (crystalloids: 65 (54–74 ml; colloids: 67.5 (60–75.25 ml) and total volume infused (crystalloids: 2575 (2000–4210) ml; colloids: 2435 (1760–3480) ml; and controls: 2210 (1658–3000) ml). Overall perioperative complications rates were similar (42.4% (95%CI 30.3–55.2%) for crystalloids and 49.2% (95%CI 40.4–58.1%) for colloids and lower compared to controls: 66.9% (95%CI 58.1–74.9)). Interestingly, a reduced number of hemorrhagic complications was observed within crystalloids: 30% (95%CI 19.6–42.9); colloids: 43% (95%CI 34.4–52.0); and controls: 62% (95%CI 52.6–69.9). There were no differences in the rate of admission to the post-anesthesia care unit or intensive care unit as well as the length of stay. Conclusions: Perioperative fluid management using a GDFT protocol with crystalloids in hip revision arthroplasty surgery was successfully implemented in daily clinical routine. Perioperative complications rates were reduced compared to a previous management without GDFT and comparable when using colloids. Trial registration: ClinicalTrials.gov identifier: NCT01753050.
- 23 June 2022
- Published by Springer Nature in Die Anaesthesiologie
- p. 1-5
58/m mit akuter zunehmender Dyspnoe nach vorangegangener Lobektomie
- 23 June 2022
- Published by Springer Nature in Die Anaesthesiologie
- p. 1-5
58/m mit akuter zunehmender Dyspnoe nach vorangegangener Lobektomie
- 1 March 2021
- Published by Springer Nature in Der Anaesthesist
- Vol. 70 (5) , 413-419
Kommentar zur aktualisierten S3-Leitlinie zur intravasalen Volumentherapie beim Erwachsenen
- 1 March 2021
- Published by Springer Nature in Der Anaesthesist
- Vol. 70 (5) , 413-419
Kommentar zur aktualisierten S3-Leitlinie zur intravasalen Volumentherapie beim Erwachsenen